ThomasSchwartzMD

Psychiatry • Syracuse, NY

SUNY Distinguished Teaching Professor SUNY-Upstate Medical University

Join to view full profile

Dr. Schwartz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Schwartz's full profile

Already have an account?

Office
719 Harrison St
Syracuse, NY 13210
Phone+1 315-464-3166

Fax+1 315-464-3282
Is this information wrong?

Education & Training

SUNY Upstate Medical UniversityResidency, Psychiatry, 1995 - 1999
SUNY Upstate Medical UniversityClass of 1995

Certifications & Licensure

NY State Medical License 1996 - 2025
American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Aripiprazole as Augmentation for TRD Start of enrollment: 2004 Jul 01
Completed
Phase 2
Xyrem for Treatment Refractory Insomnia Due to PTSD Start of enrollment: 2005 Aug 01
Withdrawn
Phase 2
A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Memantine(Namenda) as Augmentation Therapy in Patients With Generalized Anxiety Disorder Start of enrollment: 2006 Dec 01
Completed
Phase 3
An 8 Week Open-Label Study to Evaluate the Efficacy and Safety of Acamprosate Calcium (Campral) as Augmentation Therapy in Patients With Anxiety Symptoms Who Are Only Partial Responders to SSRI or SNRI Antidepressants Start of enrollment: 2006 Jun 01
Completed
Not Applicable
Cyclobenzaprine Extended Release (ER) for Fibromyalgia Start of enrollment: 2009 Jun 01
Terminated
Phase 4
Join now to see all

Publications & Presentations

PubMed

12 citations
Antidepressant efficacy and side effect burden: an updated guide for clinicians.
Tatum Kutzer, Michelle Dick, Trevor Scudamore, Mark Wiener, Thomas L. Schwartz> ;Drugs in Context. 2020 May 26
65 citations
Brexpiprazole and cariprazine: distinguishing two new atypical antipsychotics from the original dopamine stabilizer aripiprazole
Joshua S. Frankel, Thomas L. Schwartz> ;Therapeutic Advances in Psychopharmacology. 2017 Jan 1
2 citations
Neural Implications of Psychotherapy, Pharmacotherapy, and Combined Treatment in Major Depressive Disorder.
Thomas L. Schwartz, Daniel Santarsieri> ;Mens Sana Monographs. 2016 Jan 1
1 citations
Utilizing pharmacodynamic properties of second-generation antipsychotics to guide treatment.
Tomas L. Schwartz, Kristina Bedynerman> ;Drugs of Today. 2012 Apr 1
32 citations
Genetic data supporting the NMDA glutamate receptor hypothesis for schizophrenia.
Thomas L. Schwartz, Shilpa Sachdeva, Stephen M. Stahl> ;Current Pharmaceutical Design. 2012 Mar 31
20 citations
Memantine as an augmentation therapy for anxiety disorders.
Thomas L. Schwartz, Umar A. Siddiqui, Shafi Raza> ;Case Reports in Psychiatry. 2012 Feb 8
13 citations
Obesity and Psychotropics
Nikhil Nihalani, Thomas L. Schwartz, Umar A. Siddiqui, James L Megna> ;CNS Neuroscience & Therapeutics. 2012 Jan 1
29 citations
Vilazodone: a brief pharmacological and clinical review of the novel serotonin partial agonist and reuptake inhibitor
Thomas L. Schwartz, Umar A. Siddiqui, Stephen M. Stahl> ;Therapeutic Advances in Psychopharmacology. 2011 May 31
28 citations
Treatment Strategies for Dosing the Second Generation Antipsychotics
Thomas L. Schwartz, Stephen M. Stahl> ;CNS Neuroscience & Therapeutics. 2011 Apr 1
40 citations
Weight Gain, Obesity, and Psychotropic Prescribing
Nikhil Nihalani, Thomas L. Schwartz, Umar A. Siddiqui, James L Megna> ;Journal of Obesity. 2011 Jan 17
11 citations
Acamprosate Calcium as Augmentation Therapy for Anxiety Disorders
Thomas L Schwartz, Umar A. Siddiqui, Shafi Raza, Anne Costello> ;The Annals of Pharmacotherapy. 2010 Dec 1
8 citations
Armodafinil for Fibromyalgia Fatigue
Thomas L. Schwartz, Umar A. Siddiqui, Shafi Raza, Martin Morell> ;The Annals of Pharmacotherapy. 2010 Jun 15
4 citations
Pregabalin Treatment of Anxiety in Patients with Substance Use Disorders
Shafi Raza, Umar A. Siddiqui, James L Megna, Thomas L. Schwartz, Steven L. Batki> ;The Annals of Pharmacotherapy. 2010 May 1
Treatment of fibromyalgia.
Cascade EF, Kalali AH, Nihalani ND, Schwartz TL> ;Psychiatry (Edgmont). 2008-03-01
11 citations
Aripiprazole (abilify) and tardive dyskinesia.
Thomas L. Schwartz, Shafi Raza> ;P & T. 2008 Jan 1
21 citations
Mifepristone, a Glucocorticoid Antagonist for the Potential Treatment of Psychotic Major Depression
Nikhil Nihalani, Thomas L. Schwartz> ;Current Opinion in Investigational Drugs. 2007 Jul 1
32 citations
Tiagabine in anxiety disorders
Thomas L. Schwartz, Nikhil Nihalani> ;Expert Opinion on Pharmacotherapy. 2006 Oct 4
4 citations
Fibromyalgia-: a review for the psychiatrist.
Nikhil Nihalani, Thomas L. Schwartz, Susan Chlebowski> ;Psychiatry. 2006 Apr 1
16 citations
An open-label study of tiagabine as augmentation therapy for anxiety.
Thomas L. Schwartz, Nouman Azhar, Juhi Husain, Nikhil Nihalani, Mihai Simionescu, Douglas Coovert, Shefali Jindal, Syed Tirmazi> ;Annals of Clinical Psychiatry. 2005 Jul 1
7 citations
History repeats itself: pharmacodynamic trends in the treatment of anxiety disorders.
Thomas L. Schwartz, N. Nihalani, M. Simionescu, G. Hopkins> ;Current Pharmaceutical Design. 2005 Jan 1
33 citations
Psychiatric medication-induced obesity: treatment options.
Thomas L. Schwartz, Nikhil Nihalani, Subhdeep Virk, Shefali Jindal, M. Chilton> ;Obesity Reviews. 2004 Nov 1
3 citations
Effectiveness of orlistat versus diet and exercise for weight gain associated with antidepressant use: a pilot study.
Thomas L. Schwartz, Shefali Jindal, Mihai Simionescu, Nikhil Nihalani, Nouman Azhar, Syed Tirmazi, Juhi Hussein> ;Journal of Clinical Psychopharmacology. 2004 Oct 1
23 citations
An open-label study of adjunctive modafinil in patients with sedation related to serotonergic antidepressant therapy.
Thomas L. Schwartz, Nouman Azhar, Kim Cole, Geoffrey Hopkins, Nikhil Nihalani, Mihai Simionescu, Juhi Husain, Nicole Jones> ;The Journal of Clinical Psychiatry. 2004 Sep 1
9 citations
A comparison of the effectiveness of two hypnotic agents for the treatment of insomnia
Thomas L. Schwartz, Nikhil Nihalani, Subhdeep Virk, Shefali Jindal, Anne Costello, Ray Muldoon, Nouman Azhar, Juhi Hussein, Syed Tirmazi> ;The International Journal of Psychiatric Nursing Research. 2004 Aug 1
41 citations
Psychiatric medication induced obesity: an aetiologic review.
Subhdeep Virk, Thomas L. Schwartz, Shefali Jindal, Nikhil Nihalani, N. Jones> ;Obesity Reviews. 2004 Aug 1
Join now to see all

Lectures

NEI Clinical Update: MAOIs Course Two: A Mentorship on the Use of MAOIs
Neuroscience Education Institute, Huntington Beach, California - 9/15/2012
2011 NEI Global Psychopharmacology Congress
Neuroscience Education Institute, Colorado Springs, Colorado - 11/10/2011